ELV ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Elevance Health EBITDA — Trailing twelve months (TTM) (USD)
Period ending	EBITDA (USD)
Jun 30, 2026	8,505,000,000
Mar 31, 2026	9,159,000,000
Dec 31, 2025	9,658,000,000
Sep 30, 2025	10,015,000,000
Jun 30, 2025	9,873,000,000
Mar 31, 2025	10,461,000,000
Dec 31, 2024	10,482,000,000
Sep 30, 2024	10,822,000,000
Jun 30, 2024	11,159,000,000
Mar 31, 2024	10,693,000,000
Dec 31, 2023	10,490,000,000
Sep 30, 2023	10,553,000,000
Jun 30, 2023	11,005,000,000
Mar 31, 2023	10,593,000,000
Dec 31, 2022	10,126,000,000
Sep 30, 2022	10,339,000,000
Jun 30, 2022	10,096,000,000
Mar 31, 2022	10,240,000,000
Dec 31, 2021	10,025,000,000
Sep 30, 2021	9,157,000,000
Jun 30, 2021	7,504,000,000
Mar 31, 2021	8,273,000,000
Dec 31, 2020	8,176,000,000
Sep 30, 2020	8,618,000,000
Jun 30, 2020	9,698,000,000
Mar 31, 2020	7,996,000,000
Dec 31, 2019	7,864,000,000
Sep 30, 2019	7,350,000,000
Jun 30, 2019	7,093,000,000
Mar 31, 2019	7,140,200,000
Dec 31, 2018	6,953,700,000
Sep 30, 2018	6,221,500,000
Jun 30, 2018	5,996,400,000
Mar 31, 2018	5,410,800,000
Dec 31, 2017	4,926,300,000
Sep 30, 2017	5,547,300,000
Jun 30, 2017	5,437,200,000
Mar 31, 2017	5,901,400,000
Dec 31, 2016	5,875,800,000
Sep 30, 2016	5,752,300,000
Jun 30, 2016	5,634,700,000
Mar 31, 2016	5,978,500,000
Dec 31, 2015	6,191,900,000
Sep 30, 2015	6,655,400,000
Jun 30, 2015	6,840,800,000
Mar 31, 2015	6,264,600,000
Dec 31, 2014	5,819,800,000
Sep 30, 2014	5,414,300,000
Jun 30, 2014	5,226,000,000
Mar 31, 2014	5,186,600,000
Dec 31, 2013	5,341,600,000
Sep 30, 2013	5,324,300,000
Jun 30, 2013	5,408,200,000
Mar 31, 2013	5,168,400,000
Dec 31, 2012	5,118,000,000
Sep 30, 2012	5,062,600,000
Jun 30, 2012	5,021,700,000
Mar 31, 2012	4,939,300,000
Dec 31, 2011	5,025,400,000
Sep 30, 2011	5,642,500,000
Jun 30, 2011	5,736,100,000
Mar 31, 2011	5,847,300,000
Dec 31, 2010	5,737,800,000
Sep 30, 2010	8,821,900,000
Jun 30, 2010	8,677,200,000
Mar 31, 2010	8,495,900,000
Dec 31, 2009	7,957,500,000
Sep 30, 2009	4,136,100,000
Jun 30, 2009	3,576,500,000
Mar 31, 2009	3,709,400,000
Dec 31, 2008	3,697,600,000
Sep 30, 2008	4,639,400,000
Jun 30, 2008	5,464,200,000
Mar 31, 2008	5,584,300,000
Dec 31, 2007	5,941,300,000
Sep 30, 2007	5,887,600,000
Jun 30, 2007	5,880,000,000
Mar 31, 2007	6,002,200,000
Dec 31, 2006	5,922,800,000
Sep 30, 2006	5,640,200,000
Jun 30, 2006	5,237,700,000
Mar 31, 2006	4,658,700,000
Dec 31, 2005	4,362,300,000
Sep 30, 2005	3,562,800,000
Jun 30, 2005	2,918,300,000
Mar 31, 2005	2,383,900,000
Dec 31, 2004	1,860,700,000
Sep 30, 2004	1,826,100,000
Jun 30, 2004	1,769,500,000
Mar 31, 2004	1,685,500,000
Dec 31, 2003	1,595,300,000
Sep 30, 2003	1,532,000,000
Jun 30, 2003	1,428,600,000
Mar 31, 2003	1,259,300,000
Dec 31, 2002	913,600,000
Sep 30, 2002	719,000,000
Jun 30, 2002	613,200,000
Mar 31, 2002	409,000,000